ClinicalTrials HQ

An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia

An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With Achondroplasia

Active, not recruiting · NCT03989947 · Registry updated 2026-03-13
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
An Extension Study to Evaluate Safety and Efficacy of BMN 111 in Children With AchondroplasiaBone Diseases, Developmental, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dwarfism, achondroplasia, bone disorder, endocrine system disorder, hereditary disease, musculoskeletal system disorder, osteochondrodysplasiaActive, not recruitingPhase 22026-03-13NCT03989947

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
BioMarin Pharmaceutical32

16 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Alfred I. DuPont Hospital for ChildrenWilmingtonUnited States7
Ann Robert and H. Lurie Children's Hospital of ChicagoChicagoUnited States1
Baylor College of MedicineHoustonUnited States306
Children's Hospital & Research Center OaklandOaklandUnited States4
Cincinnati Childrens HospitalCincinnatiUnited States9
Emory UniversityDecaturUnited States2
Guy's and St. Thomas NHS Foundation Trust Evelina Children's HospitalLondonUnited Kingdom1
Harbor - UCLA Medical CenterTorranceUnited States3
Medical College of Wisconsin, Children's HospitalMilwaukeeUnited States4
Murdoch Children's Research InstituteParkvilleAustralia21
Osaka UniversityOsakaJapan1
Saitama Children's Medical CenterSaitamaJapan1
Sheffield Children's NHS Foundation TrustSheffieldUnited Kingdom1
The Children's Hospital at WestmeadWestmeadAustralia49
Tokushima University HospitalTokushimaJapan1
Vanderbilt University Medical CenterNashvilleUnited States3